CARE BEYOND THE CLINIC
Respiri is leading the way in the development of innovative eHealth solutions that aim to improve the management of chronic and costly respiratory disorders such as asthma.
READ MOREVision
A world without the challenges of asthma.
Mission
To improve asthma management by
extending care beyond the clinic.
Values
We are Respectful
We are Accountable
We are One Team
We are Innovative
ASTHMA CARE BEYOND THE CLINIC
Introducing wheezo™, a new innovative asthma management tool. wheezo is an eHealth app combined with a simple, easy to use, handheld device. wheezo records breathing over 30 seconds and analyses the recording for wheeze. The engaging app also allows users to track other important asthma symptoms, triggers, medication usage, location specific weather and environmental factors (pollen, pollution, air quality).
RESPIRI NEWS
The latest news from Respiri Limited.
Respiri rolls out wheezo device distribution with Pharmacy 4 Less group
Special Report: Respiratory health company Respiri has entered into a sales and marketing partnership for its wheezo devices for asthma management with Pharmacy 4 Less.
Respiri teams up with Pharmacy 4 Less group for wheezo sales
Respiratory health technology company Respiri (ASX: RSH) has announced a new sales and marketing partnership with the Pharmacy 4 Less group for the sale of its asthma management device wheezo commencing early next year.
Respiri reasserts full-year revenue guidance after locking in key product order, shares climb
Special Report: Respiri’s deal with Cipla will allow it to boost distribution of its wheezo asthma management device via direct pharmacy sales.
RESPIRI PARTNERS
Carlton Football Club AFLW team
Respiri recently announced its partnership with the Carlton Football Club AFLW for 2021 Season. The partnership announcement will see wheezo supported by the Carlton Football Club AFLW team and bring awareness of the importance of asthma management to the forefront of the community.
Australian Patients Association
Respiri recently announced their partnership with Australian Patients Association (APA) to support patients living with asthma through Respiri’s wheezo Experiential Program. The APA is connected with 1.1 million Australian patients and 15,000 Health Care Practitioners.
Pharmacy Guild Australia
Respiri recently announced the two year agreement with Guild Learning and Development (GuildED) and will collaboratively develop a Continuing Professional Development (CPD) online training course for pharmacists on optimising asthma patient management.
MICHAEL CLARKE
Respiri’s first brand ambassador. Hear from the former
Australian Cricket Captain on why he’s partnered with
Respiri to help bring wheezo to market.
JOIN OUR NEWSLETTER
Be the first to hear of Respiri’s latest news and subscribe to the bi-monthly newsletter here.